Showing 1 - 8 results of 8 for search 'Dean G. Campelj', query time: 0.02s Refine Results
  1. 1
    Chemotherapy-Induced Myopathy: The Dark Side of the Cachexia Sphere

    Chemotherapy-Induced Myopathy: The Dark Side of the Cachexia Sphere by Dean G. Campelj, Craig A. Goodman, Emma Rybalka

    Published 2021-07-01
    Get full text
    Article
  2. 2
    Cachectic muscle wasting in acute myeloid leukaemia: a sleeping giant with dire clinical consequences

    Cachectic muscle wasting in acute myeloid leukaemia: a sleeping giant with dire clinical consequences by Dean G. Campelj, Cara A. Timpani, Emma Rybalka

    Published 2022-02-01
    Get full text
    Article
  3. 3
    Irinotecan-Induced Gastrointestinal Dysfunction Is Associated with Enteric Neuropathy, but Increased Numbers of Cholinergic Myenteric Neurons

    Irinotecan-Induced Gastrointestinal Dysfunction Is Associated with Enteric Neuropathy, but Increased Numbers of Cholinergic Myenteric Neurons by Rachel M. McQuade, Vanesa Stojanovska, Elizabeth L. Donald, Ahmed A. Rahman, Dean G. Campelj, Dean G. Campelj, Dean G. Campelj, Raquel Abalo, Emma Rybalka, Emma Rybalka, Emma Rybalka, Joel C. Bornstein, Kulmira Nurgali

    Published 2017-06-01
    Get full text
    Article
  4. 4
    The Failed Clinical Story of Myostatin Inhibitors against Duchenne Muscular Dystrophy: Exploring the Biology behind the Battle

    The Failed Clinical Story of Myostatin Inhibitors against Duchenne Muscular Dystrophy: Exploring the Biology behind the Battle by Emma Rybalka, Cara A. Timpani, Danielle A. Debruin, Ryan M. Bagaric, Dean G. Campelj, Alan Hayes

    Published 2020-12-01
    Get full text
    Article
  5. 5
    The Paradoxical Effect of PARP Inhibitor BGP-15 on Irinotecan-Induced Cachexia and Skeletal Muscle Dysfunction

    The Paradoxical Effect of PARP Inhibitor BGP-15 on Irinotecan-Induced Cachexia and Skeletal Muscle Dysfunction by Dean G. Campelj, Cara A. Timpani, Aaron C. Petersen, Alan Hayes, Craig A. Goodman, Emma Rybalka

    Published 2020-12-01
    Get full text
    Article
  6. 6
    Standard of care versus new-wave corticosteroids in the treatment of Duchenne muscular dystrophy: Can we do better?

    Standard of care versus new-wave corticosteroids in the treatment of Duchenne muscular dystrophy: Can we do better? by Stephanie Kourakis, Cara A. Timpani, Dean G. Campelj, Patricia Hafner, Nuri Gueven, Dirk Fischer, Emma Rybalka

    Published 2021-03-01
    Get full text
    Article
  7. 7
    Metronomic 5-Fluorouracil Delivery Primes Skeletal Muscle for Myopathy but Does Not Cause Cachexia

    Metronomic 5-Fluorouracil Delivery Primes Skeletal Muscle for Myopathy but Does Not Cause Cachexia by Dean G. Campelj, Cara A. Timpani, Tabitha Cree, Aaron C. Petersen, Alan Hayes, Craig A. Goodman, Emma Rybalka

    Published 2021-05-01
    Get full text
    Article
  8. 8
    Dimethyl fumarate modulates the dystrophic disease program following short-term treatment

    Dimethyl fumarate modulates the dystrophic disease program following short-term treatment by Cara A. Timpani, Stephanie Kourakis, Danielle A. Debruin, Dean G. Campelj, Nancy Pompeani, Narges Dargahi, Angelo P. Bautista, Ryan M. Bagaric, Elya J. Ritenis, Lauren Sahakian, Didier Debrincat, Nicole Stupka, Patricia Hafner, Peter G. Arthur, Jessica R. Terrill, Vasso Apostolopoulos, Judy B. de Haan, Nuri Guven, Dirk Fischer, Emma Rybalka

    Published 2023-11-01
    Get full text
    Article

Search Tools: